SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,537.72 628.04
( 0.82%)

Global Indices

Nasdaq

53,487.79 123.39
(0.23%)

Dow Jones

7,729.14 16.38
(0.21%)

Hang Seng

66,220.29 893.87
(1.37%)

Nikkei 225

10,747.45 19.41
(0.18%)

Forex

USD-INR

95.70 0.10
(0.10%)

EUR-INR

110.78 0.02
(0.01%)

GBP-INR

129.52 -0.04
(-0.03%)

JPY-INR

0.60 0.00
(-0.13%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Aarti Drugs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524348

INE767A01016

153.9158541

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AARTIDRUGS

21.56

3728.38

EPS(TTM)

Face Value()

Div & Yield %

18.95

0.49

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	2173.65	2266.91	2497.97	2251.17	1914.89	1634.92
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	2173.65	2266.91	2497.97	2251.17	1914.89	1634.92
Other Income	13.57	4.18	2.23	4.77	9.69	9.44
Stock Adjustments	-22.00	-26.77	6.72	77.94	9.08	53.94
Total Income	2165.22	2244.32	2506.92	2333.88	1933.66	1698.30
EXPENDITURE :
Raw Materials	1376.63	1476.42	1723.25	1558.47	1148.99	1099.82
Power & Fuel Cost	149.05	151.64	153.45	126.05	95.64	101.04
Employee Cost	73.88	70.20	64.30	57.17	55.60	52.65
Other Manufacturing Expenses	203.72	201.92	182.71	171.26	138.99	122.62
Selling & Administrative Expenses	74.83	63.27	89.25	89.75	76.70	59.39
Miscellaneous Expenses	8.37	7.52	5.68	5.24	6.72	5.40
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	1886.48	1970.96	2218.64	2007.95	1522.64	1440.92
Operating Profit	278.74	273.36	288.28	325.94	411.02	257.38
Interest	32.20	33.21	36.18	23.05	25.71	35.74
Gross Profit	246.54	240.15	252.10	302.89	385.31	221.64
Depreciation	47.79	47.67	47.29	47.39	47.60	46.67
Profit Before Tax	198.75	192.48	204.81	255.50	337.71	174.97
Tax	37.94	49.60	53.25	65.50	84.50	49.55
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	3.50	1.00	-1.25	-5.00	-4.50	-10.25
Reported Net Profit	157.31	141.88	152.81	195.00	257.71	135.67
Extraordinary Items	0.00	0.00	0.00	0.00	0.17	6.35
Adjusted Net Profit	157.31	141.88	152.81	195.00	257.54	129.32
Adjustment below Net Profit	-58.28	-13.32	0.00	-51.64	-69.90	-26.90
P & L Balance brought forward	1052.31	947.13	818.86	704.26	565.52	475.07
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	24.86	23.38	24.54	28.76	49.07	18.32
P & L Balance carried down	1126.48	1052.31	947.13	818.86	704.26	565.52
Dividend	9.13	9.19	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	10.00	10.00	10.00	10.00	25.00	20.00
Dividend Per Share(Rs)	1.00	1.00	1.00	1.00	2.50	2.00
Earnings Per Share-Unit Curr	17.24	15.43	16.50	21.06	27.65	58.23
Earnings Per Share(Adj)-Unit Curr	17.24	15.43	16.50	21.06	27.65	14.56
Book Value-Unit Curr	137.10	127.83	120.34	104.99	92.23	266.86
Book Value(Adj)-Unit Curr	137.10	127.83	120.34	104.99	92.23	66.72

77,537.72 628.04 ( 0.82%)

53,487.79 123.39 (0.23%)

7,729.14 16.38 (0.21%)

66,220.29 893.87 (1.37%)

10,747.45 19.41 (0.18%)

95.70 0.10 (0.10%)

110.78 0.02 (0.01%)

129.52 -0.04 (-0.03%)

0.60 0.00 (-0.13%)